Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling

Cancer stem cells (CSCs) are a small population of cancer cells that exhibit stemness. These cells contribute to cancer metastasis, treatment resistance, and relapse following therapy; therefore, they may cause malignancy and reduce the success of cancer treatment. Nuclear factor kappa B- (NF-κB-) m...

Full description

Saved in:
Bibliographic Details
Main Authors: Da-Wei Yeh, Li-Rung Huang, Ya-Wen Chen, Chi-Ying F. Huang, Tsung-Hsien Chuang
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/4368101
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568406845423616
author Da-Wei Yeh
Li-Rung Huang
Ya-Wen Chen
Chi-Ying F. Huang
Tsung-Hsien Chuang
author_facet Da-Wei Yeh
Li-Rung Huang
Ya-Wen Chen
Chi-Ying F. Huang
Tsung-Hsien Chuang
author_sort Da-Wei Yeh
collection DOAJ
description Cancer stem cells (CSCs) are a small population of cancer cells that exhibit stemness. These cells contribute to cancer metastasis, treatment resistance, and relapse following therapy; therefore, they may cause malignancy and reduce the success of cancer treatment. Nuclear factor kappa B- (NF-κB-) mediated inflammatory responses increase stemness in cancer cells, and CSCs constitutively exhibit higher NF-κB activation, which in turn increases their stemness. These opposite effects form a positive feedback loop that further amplifies inflammation and stemness in cancer cells, thereby expanding CSC populations in the tumor. Toll-like receptors (TLRs) activate NF-κB-mediated inflammatory responses when stimulated by carcinogenic microbes and endogenous molecules released from cells killed during cancer treatment. NF-κB activation by extrinsic TLR ligands increases stemness in cancer cells. Moreover, it was recently shown that increased NF-κB activity and inflammatory responses in CSCs may be caused by altered TLR signaling during the enrichment of stemness in cancer cells. Thus, the activation of TLR signaling by extrinsic and intrinsic factors drives a positive interplay between inflammation and stemness in cancer cells.
format Article
id doaj-art-0dd26966599b48ad9810b950eee570a0
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-0dd26966599b48ad9810b950eee570a02025-02-03T00:59:03ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/43681014368101Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor SignalingDa-Wei Yeh0Li-Rung Huang1Ya-Wen Chen2Chi-Ying F. Huang3Tsung-Hsien Chuang4Immunology Research Center, National Health Research Institutes, Miaoli 35053, TaiwanInstitute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli 35053, TaiwanNational Institute of Cancer Research, National Health Research Institutes, Miaoli 35053, TaiwanInstitute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 11221, TaiwanImmunology Research Center, National Health Research Institutes, Miaoli 35053, TaiwanCancer stem cells (CSCs) are a small population of cancer cells that exhibit stemness. These cells contribute to cancer metastasis, treatment resistance, and relapse following therapy; therefore, they may cause malignancy and reduce the success of cancer treatment. Nuclear factor kappa B- (NF-κB-) mediated inflammatory responses increase stemness in cancer cells, and CSCs constitutively exhibit higher NF-κB activation, which in turn increases their stemness. These opposite effects form a positive feedback loop that further amplifies inflammation and stemness in cancer cells, thereby expanding CSC populations in the tumor. Toll-like receptors (TLRs) activate NF-κB-mediated inflammatory responses when stimulated by carcinogenic microbes and endogenous molecules released from cells killed during cancer treatment. NF-κB activation by extrinsic TLR ligands increases stemness in cancer cells. Moreover, it was recently shown that increased NF-κB activity and inflammatory responses in CSCs may be caused by altered TLR signaling during the enrichment of stemness in cancer cells. Thus, the activation of TLR signaling by extrinsic and intrinsic factors drives a positive interplay between inflammation and stemness in cancer cells.http://dx.doi.org/10.1155/2016/4368101
spellingShingle Da-Wei Yeh
Li-Rung Huang
Ya-Wen Chen
Chi-Ying F. Huang
Tsung-Hsien Chuang
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
Journal of Immunology Research
title Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
title_full Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
title_fullStr Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
title_full_unstemmed Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
title_short Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
title_sort interplay between inflammation and stemness in cancer cells the role of toll like receptor signaling
url http://dx.doi.org/10.1155/2016/4368101
work_keys_str_mv AT daweiyeh interplaybetweeninflammationandstemnessincancercellstheroleoftolllikereceptorsignaling
AT lirunghuang interplaybetweeninflammationandstemnessincancercellstheroleoftolllikereceptorsignaling
AT yawenchen interplaybetweeninflammationandstemnessincancercellstheroleoftolllikereceptorsignaling
AT chiyingfhuang interplaybetweeninflammationandstemnessincancercellstheroleoftolllikereceptorsignaling
AT tsunghsienchuang interplaybetweeninflammationandstemnessincancercellstheroleoftolllikereceptorsignaling